Shaei Y. Huang

Person

Lansdale, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of checkpoint kinases
- Patent number 7,501,435
- Issue date Mar 10, 2009
- Merck & Co., Inc.
- Kenneth L. Arrington
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted acylhydroxamic acids and method of reducing TNFαlevels
- Patent number 7,345,062
- Issue date Mar 18, 2008
- Celgene Corporation
- Hon-Wah Man
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds for treating dyslipidemic conditions
- Patent number 7,125,865
- Issue date Oct 24, 2006
- Merck & Co., Inc.
- A. Brian Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted acylhydroxamic acids and method of reducing TNFα...
- Patent number 6,699,899
- Issue date Mar 2, 2004
- Celgene Corporation
- Hon-Wah Man
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
OXAZOLOBENZIMIDAZOLE DERIVATIVES
- Publication number 20110124661
- Publication date May 26, 2011
- Merck Sharp & Dohme Corp.
- Edward J. Brnardic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Checkpoint Kinases
- Publication number 20090258852
- Publication date Oct 15, 2009
- Kenneth L. Arrington
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Checkpoint Kinases
- Publication number 20080280902
- Publication date Nov 13, 2008
- Mark E. Fraley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted acylhydroxamic acids and method of reducing TNFalpha le...
- Publication number 20080280967
- Publication date Nov 13, 2008
- CELGENE CORPORATION
- Hon-Wah Man
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Checkpoint Kinases
- Publication number 20080004259
- Publication date Jan 3, 2008
- Kenneth L. Arrington
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of checkpoint kinases
- Publication number 20070254879
- Publication date Nov 1, 2007
- Kenneth L. Arrington
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic compounds for treating dyslipidemic conditions
- Publication number 20060178398
- Publication date Aug 10, 2006
- Alan D. Adams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic compounds for treating dyslipidemic conditions
- Publication number 20050239769
- Publication date Oct 27, 2005
- A. Brian Jones
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic compounds for treating dyslipidemic conditions
- Publication number 20050113419
- Publication date May 26, 2005
- Shaei Y. Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic compounds for treating dyslipidemic conditions
- Publication number 20050014807
- Publication date Jan 20, 2005
- Alan D Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic compounds for treating dyslipidemic conditions
- Publication number 20040266849
- Publication date Dec 30, 2004
- Alan D Adams
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted acylhydroxamic acids and method of reducing TNFalpha le...
- Publication number 20040167174
- Publication date Aug 26, 2004
- Celgene
- Hon-Wah Man
- C07 - ORGANIC CHEMISTRY

Shaei Y. Huang

Person

Patents Grantslast 30 patents

Inhibitors of checkpoint kinases

Substituted acylhydroxamic acids and method of reducing TNFαlevels

Therapeutic compounds for treating dyslipidemic conditions

Substituted acylhydroxamic acids and method of reducing TNF&#x03B1;...

Patents Applicationslast 30 patents

OXAZOLOBENZIMIDAZOLE DERIVATIVES

Inhibitors of Checkpoint Kinases

Inhibitors of Checkpoint Kinases

Substituted acylhydroxamic acids and method of reducing TNFalpha le...

Inhibitors of Checkpoint Kinases

Inhibitors of checkpoint kinases

Therapeutic compounds for treating dyslipidemic conditions

Therapeutic compounds for treating dyslipidemic conditions

Therapeutic compounds for treating dyslipidemic conditions

Therapeutic compounds for treating dyslipidemic conditions

Therapeutic compounds for treating dyslipidemic conditions

Substituted acylhydroxamic acids and method of reducing TNFalpha le...

Substituted acylhydroxamic acids and method of reducing TNFα...